The 22q11 PRODH/DGCR6 deletion is frequent in hyperprolinemic subjects but is not a strong risk factor for ASD.

Anne Claire Richard 1 Anne Rovelet-Lecrux 1 Elsa Delaby 2 Camille Charbonnier 1 Bhooma Thiruvahindrapuram 3 Eli Hatchwell 4 Peggy Eis 4 Alexandra Afenjar 5 Brigitte Gilbert Dussardier 6 Stephen Scherer 3, 7 Catalina Betancur 2 Dominique Campion 1, 8, *
* Auteur correspondant
1 GMFC - Génétique du cancer et des maladies neuropsychiatriques
2 NPS - Neuroscience Paris Seine
3 Program in Genetics and Genomic Biology
4 Population Diagnostics, Inc.
5 Service de Neuropédiatrie
6 Service de Génétique, CHU Poitiers
7 McLaughlin Centre and Department of Molecular Genetics
8 Centre Hospitalier du Rouvray
Abstract : The proline dehydrogenase (PRODH) gene maps to 22q11.2 in the region deleted in the velo-cardio-facial syndrome (VCFS). A moderate to severe reduction (>50%) in PRODH activity resulting from recessive deletions and/or missense mutations has been shown to cause type 1 hyperprolinemia (HPI). Autistic features have been reported as a common clinical manifestation of HPI. Here we studied the frequency of a recurrent small 22q11.2 deletion encompassing PRODH and the neighboring DGCR6 gene in three case-control studies, one comprising HPI patients (n=83), and the other two comprising autism spectrum disorder (ASD) patients (total of n=2800), analyzed with high-resolution microarrays. We found that the PRODH deletion is a strong risk factor for HPI (OR = 50.7; 95% CI = 7.5-2147) but not for ASD (p=0.4, OR= 0.6-3.3). This result indicates either that the suggested association between ASD and HPI is spurious and results from a bias leading to the preferential inclusion of ASD patients in HPI series, or that HPI is present in only a very small subset of ASD patients. In this latter case, a very large sample size would be required to detect an association between the PRODH deletion and ASD in a case-control study.
Keywords : proline dehydrogenase copy number variant hyperprolinemia autism 22q11.2 deletion
Type de document :
Article dans une revue
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Wiley, 2016, 171B (3), pp.377-82. 〈10.1002/ajmg.b.32416〉
Liste complète des métadonnées

Littérature citée [24 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-01289348
Contributeur : Catalina Betancur <>
Soumis le : mercredi 16 mars 2016 - 15:33:16
Dernière modification le : vendredi 31 août 2018 - 08:57:21

Fichier

Richard PRODH AJMGB 2016.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

UPMC | NPS | COMUE-NORMANDIE | IBPS | NPS-01 | UNIROUEN

Citation

Anne Claire Richard, Anne Rovelet-Lecrux, Elsa Delaby, Camille Charbonnier, Bhooma Thiruvahindrapuram, et al.. The 22q11 PRODH/DGCR6 deletion is frequent in hyperprolinemic subjects but is not a strong risk factor for ASD.. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Wiley, 2016, 171B (3), pp.377-82. 〈10.1002/ajmg.b.32416〉. 〈inserm-01289348〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

439

Téléchargements de fichiers

215

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD